Kineticos Life Sciences Management
Kineticos Ventures is a specialized management consulting and venture capital firm based in Raleigh, North Carolina, focused on the life sciences industry. Established in 2007, the firm invests in biotechnology companies that aim to innovate drug development, disease diagnosis, and patient treatment, with particular emphasis on areas of significant medical need such as oncology, neurosciences, and rare diseases. Kineticos Ventures is particularly interested in disruptive technologies, including cell and gene therapy, gene editing, and mRNA/RNAi, which have the potential to transform medical practices. In addition to biotechnology, the firm also seeks opportunities in contract services, enabling technologies, medtech, and the antimicrobial resistance sectors.
EnteroBiotix Limited is a biotechnology company based in Edinburgh, United Kingdom, that specializes in the research, development, and commercialization of orally available products for fecal microbiota transplantation. Founded in 2017, the company focuses on creating microbiome-modulating drugs derived from bacterial communities in the human gastrointestinal tract. These products aim to restore health and prevent bacterial infections by addressing imbalances in gut bacteria associated with various diseases. EnteroBiotix is dedicated to developing both allogenic and autologous microbial therapeutics to meet the needs of patients with serious unmet medical conditions, thereby enabling healthcare providers to effectively prevent and treat debilitating infections and diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.